How to best measure HIV reservoirs?

被引:44
作者
Rouzioux, Christine [1 ]
Richman, Douglas [2 ,3 ]
机构
[1] Paris Descartes Univ, Necker Hosp, Dept Virol, Paris, France
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
基金
美国国家卫生研究院;
关键词
HIV latency; markers of HIV reservoirs; quantification; CD4(+) T-CELLS; SUPPRESSIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; HAART-TREATED PATIENTS; DISEASE PROGRESSION; INFECTED INDIVIDUALS; PERIPHERAL-BLOOD; DEACETYLASE INHIBITORS; ELITE CONTROLLERS; DNA LEVEL;
D O I
10.1097/COH.0b013e32835fc619
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The persistence of HIV within infected CD4(+) T cells is a major obstacle to eradication, and assessment of the strategies to reduce HIV reservoirs is one of the major challenges. Measuring HIV reservoirs accurately will be necessary to assess those strategies. The objective of this review is to present the most recent studies that may help to define the best markers to measure HIV reservoirs. Recent findings Recent findings have shown that multiple assays can be used to quantify the different analytes that reflect the HIV reservoirs. They have provided new insights, but lack of standardization has made cross-comparisons of data difficult. No single best assay for measuring HIV reservoirs has been identified and these assays often address different questions, such as the size of the reservoirs, the composition of the reservoirs, or the capacity of latent reservoirs to produce virus. A consensus on what values reflect robust conclusions will have to wait for the generation of additional results. Summary In conclusion, there is a compelling need for investigators to optimize assays and share protocol reagents and specimens to permit the validation, comparison, and standardization of techniques. There is an important need for validated, high-throughput, sensitive, and accurate assays that can detect changes in HIV reservoir size in order to assess the impact of candidate therapies.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 57 条
[1]   Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs [J].
Agosto, Luis M. ;
Liszewski, Megan K. ;
Mexas, Angela ;
Graf, Erin ;
Pace, Matthew ;
Yu, Jianqing J. ;
Bhandoola, Avinash ;
O'Doherty, Una .
VIROLOGY, 2011, 409 (01) :46-53
[2]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 487 (7408) :482-U1650
[3]   Elite controllers as a model of functional cure [J].
Autran, Brigitte ;
Descours, Benjamin ;
Avettand-Fenoel, Veronique ;
Rouzioux, Christine .
CURRENT OPINION IN HIV AND AIDS, 2011, 6 (03) :181-187
[4]   HIV-1 DNA for the measurement of the HIV reservoir is predictive of disease progression in seroconverters whatever the mode of result expression is [J].
Avettand-Fenoel, Veronique ;
Boufassa, Faroudy ;
Galimand, Julie ;
Meyer, Laurence ;
Rouzioux, Christine .
JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (04) :399-404
[5]   LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area (ANRS CO 01) [J].
Avettand-Fenol, Veronique ;
Chaix, Marie-Laure ;
Blanche, Stephane ;
Burgard, Marianne ;
Floch, Corinne ;
Toure, Kadidia ;
Allemon, Marie-Christine ;
Warszawski, Josiane ;
Rouzioux, Christine .
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (02) :217-223
[6]   Effect of Histone Deacetylase Inhibitors on HIV Production in Latently Infected, Resting CD4+ T Cells From Infected Individuals Receiving Effective Antiretroviral Therapy [J].
Blazkova, Jana ;
Chun, Tae-Wook ;
Belay, Bietel W. ;
Murray, Danielle ;
Justement, J. Shawn ;
Funk, Emily K. ;
Nelson, Amy ;
Hallahan, Claire W. ;
Moir, Susan ;
Wender, Paul A. ;
Fauci, Anthony S. .
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (05) :765-769
[7]   Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients [J].
Bouchat, Sophie ;
Gatot, Jean-Stephane ;
Kabeya, Kabamba ;
Cardona, Christelle ;
Colin, Laurence ;
Herbein, Georges ;
De Wit, Stephane ;
Clumeck, Nathan ;
Lambotte, Olivier ;
Rouzioux, Christine ;
Rohr, Olivier ;
Van Lint, Carine .
AIDS, 2012, 26 (12) :1473-1482
[8]   CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract [J].
Brenchley, JM ;
Schacker, TW ;
Ruff, LE ;
Price, DA ;
Taylor, JH ;
Beilman, GJ ;
Nguyen, PL ;
Khoruts, A ;
Larson, M ;
Haase, AT ;
Douek, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (06) :749-759
[9]   HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects [J].
Buzon, Maria J. ;
Massanella, Marta ;
Llibre, Josep M. ;
Esteve, Anna ;
Dahl, Viktor ;
Puertas, Maria C. ;
Gatell, Josep M. ;
Domingo, Pere ;
Paredes, Roger ;
Sharkey, Mark ;
Palmer, Sarah ;
Stevenson, Mario ;
Clotet, Bonaventura ;
Blanco, Julia ;
Martinez-Picado, Javier .
NATURE MEDICINE, 2010, 16 (04) :460-U143
[10]   HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation [J].
Chomont, Nicolas ;
El-Far, Mohamed ;
Ancuta, Petronela ;
Trautmann, Lydie ;
Procopio, Francesco A. ;
Yassine-Diab, Bader ;
Boucher, Genevieve ;
Boulassel, Mohamed-Rachid ;
Ghattas, Georges ;
Brenchley, Jason M. ;
Schacker, Timothy W. ;
Hill, Brenna J. ;
Douek, Daniel C. ;
Routy, Jean-Pierre ;
Haddad, Elias K. ;
Sekaly, Rafick-Pierre .
NATURE MEDICINE, 2009, 15 (08) :893-U92